Raymond James Financial Services Advisors, Inc. Veracyte, Inc. Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Veracyte, Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 83,004 shares of VCYT stock, worth $3.53 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
83,004Holding current value
$3.53 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VCYT
# of Institutions
307Shares Held
81.7MCall Options Held
134KPut Options Held
13.3K-
Black Rock Inc. New York, NY7.79MShares$331 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.75MShares$329 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.02MShares$213 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.92MShares$209 Million1.59% of portfolio
-
Wellington Management Group LLP Boston, MA4.23MShares$180 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $3.04B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...